Abbott Laboratories (ABT) News Today $132.35 +0.07 (+0.05%) Closing price 06/18/2025 03:59 PM EasternExtended Trading$132.96 +0.61 (+0.46%) As of 06/18/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is Abbott Laboratories Up Today?Abbott Laboratories (ABT) shares have risen, as investors respond to recent positive developments in product approvals, strategic partnerships and strong institutional support. Health Canada grants approval to Abbott's i-STAT TBI test, enabling rapid bedside concussion detection with whole blood samples. Abbott and MSD form a partnership to distribute an oral anti-diabetic portfolio in India, expanding the company’s footprint in a key emerging market. Institutional investors own 81% of ABT shares, reflecting high confidence from large financial stakeholders. Leerink Partners initiates coverage on ABT with a “Hold” rating, forecasting $1.26 EPS for Q2 2025 and $5.15 for FY2025, broadly in line with consensus estimates and projecting steady growth through FY2029. Zacks notes ABT as one of its most-watched stocks, prompting analysis of the company’s valuation and outlook for potential investors. Posted 6h agoAI Generated. May Contain Errors. ABT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period FY2025 Earnings Forecast for ABT Issued By Leerink PartnrsJune 20 at 1:33 AM | americanbankingnews.comAbbott Laboratories (NYSE:ABT) is a favorite amongst institutional investors who own 81%June 19 at 9:25 AM | finance.yahoo.comAbbott Laboratories (NYSE:ABT) Shares Sold by Norris Perne & French LLP MINorris Perne & French LLP MI lowered its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 1.4% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 223,227 shares of the healthcare product maker's stockJune 19 at 7:40 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Holdings Boosted by ORG Wealth Partners LLCORG Wealth Partners LLC boosted its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 7.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 46,155 shares of the healthcare product maker's stock after purchJune 19 at 7:23 AM | marketbeat.comPlimoth Trust Co. LLC Decreases Position in Abbott Laboratories (NYSE:ABT)Plimoth Trust Co. LLC decreased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 13.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 26,197 shares of the healthcare product makeJune 19 at 7:05 AM | marketbeat.comEnvestnet Portfolio Solutions Inc. Reduces Stake in Abbott Laboratories (NYSE:ABT)Envestnet Portfolio Solutions Inc. decreased its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 41.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 135,902 shares of the healthcareJune 19 at 6:53 AM | marketbeat.comCatalina Capital Group LLC Sells 3,742 Shares of Abbott Laboratories (NYSE:ABT)Catalina Capital Group LLC decreased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 64.4% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,069 shares of the healthcare product maker's stock after selling 3,742 shares during tJune 19 at 6:53 AM | marketbeat.comJohnson Investment Counsel Inc. Has $132.64 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)Johnson Investment Counsel Inc. reduced its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 1.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 999,886 shares of the healthcare product makerJune 19 at 5:33 AM | marketbeat.comCWA Asset Management Group LLC Grows Position in Abbott Laboratories (NYSE:ABT)CWA Asset Management Group LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 23.6% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,322 shares of the healthcare product maker's stock after buying an addJune 19 at 5:15 AM | marketbeat.comWealth Enhancement Advisory Services LLC Lowers Position in Abbott Laboratories (NYSE:ABT)Wealth Enhancement Advisory Services LLC decreased its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 4.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,074,844 shares of the hJune 19 at 3:45 AM | marketbeat.comQ2 Earnings Forecast for ABT Issued By Leerink PartnrsJune 19 at 1:55 AM | americanbankingnews.comWhat is Leerink Partnrs' Estimate for ABT FY2025 Earnings?Abbott Laboratories (NYSE:ABT - Free Report) - Equities research analysts at Leerink Partnrs issued their FY2025 earnings per share (EPS) estimates for shares of Abbott Laboratories in a research report issued on Monday, June 16th. Leerink Partnrs analyst M. Kratky forecasts that the healthcare pJune 18 at 7:33 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Purchased by State of Alaska Department of RevenueState of Alaska Department of Revenue raised its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 24.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 246,749 shares of the healthcare produJune 18 at 7:09 AM | marketbeat.comAnalyst IMS Investment Management Services Ltd. Invests $797,000 in Abbott Laboratories (NYSE:ABT)Analyst IMS Investment Management Services Ltd. bought a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 6,006 shares of the healthcareJune 18 at 6:59 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by PUREfi Wealth LLCPUREfi Wealth LLC reduced its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 24.8% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 6,603 shares of the healthcare product maker's stock after selling 2,175 shares during the period. Abbott LJune 18 at 6:42 AM | marketbeat.comPrentiss Smith & Co. Inc. Sells 12,618 Shares of Abbott Laboratories (NYSE:ABT)Prentiss Smith & Co. Inc. lessened its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 21.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 44,965 shares of the healthcare product maker's stock after sellingJune 18 at 6:29 AM | marketbeat.comKingswood Wealth Advisors LLC Acquires 17,074 Shares of Abbott Laboratories (NYSE:ABT)Kingswood Wealth Advisors LLC boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 161.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,682 shares of the healthcare product maJune 18 at 6:29 AM | marketbeat.comWolf Group Capital Advisors Takes $405,000 Position in Abbott Laboratories (NYSE:ABT)Wolf Group Capital Advisors bought a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund bought 3,050 shares of the healthcare product maker's stock, valued at approximately $405,000. OtJune 18 at 5:50 AM | marketbeat.comCushing Capital Partners LLC Purchases New Holdings in Abbott Laboratories (NYSE:ABT)Cushing Capital Partners LLC acquired a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 6,058 shares of the healthcare product maker's stock, valued at approximately $804,000. OtheJune 18 at 5:32 AM | marketbeat.comHemenway Trust Co LLC Has $49.37 Million Stock Position in Abbott Laboratories (NYSE:ABT)Hemenway Trust Co LLC increased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 4.1% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 372,188 shares of the healthcare product maker's stock after buying an additional 14,775 shareJune 18 at 5:24 AM | marketbeat.comLeerink Partners Begins Coverage on ABTJune 18 at 5:22 AM | msn.comRobertson Stephens Wealth Management LLC Sells 3,238 Shares of Abbott Laboratories (NYSE:ABT)Robertson Stephens Wealth Management LLC lessened its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 13.4% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,983 shares of the healthcare product maker's stJune 18 at 4:41 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Coverage Initiated at Leerink PartnersJune 18 at 2:14 AM | americanbankingnews.comAbbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes ManagementJune 17 at 9:18 AM | finance.yahoo.comAbbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings?June 17 at 9:18 AM | msn.comWhat is Leerink Partnrs' Estimate for ABT Q2 Earnings?Abbott Laboratories (NYSE:ABT - Free Report) - Stock analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Abbott Laboratories in a report issued on Monday, June 16th. Leerink Partnrs analyst M. Kratky anticipates that the healthcare product maker will post eJune 17 at 7:56 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Upgraded at Leerink PartnrsLeerink Partnrs raised Abbott Laboratories to a "hold" rating in a research report on Monday.June 17 at 7:50 AM | marketbeat.comCENTRAL TRUST Co Sells 3,822 Shares of Abbott Laboratories (NYSE:ABT)CENTRAL TRUST Co trimmed its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 2.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 146,116 shares of the healthcare product maker's stock after selling 3,822 shares durJune 17 at 7:33 AM | marketbeat.comWendell David Associates Inc. Sells 1,889 Shares of Abbott Laboratories (NYSE:ABT)Wendell David Associates Inc. trimmed its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 0.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 220,319 shares of the healthcare producJune 17 at 7:07 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by Demars Financial Group LLCDemars Financial Group LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 16.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 323,577 shares of the healthcare product maker's stock after purchasing an additional 4June 17 at 6:47 AM | marketbeat.com2,689 Shares in Abbott Laboratories (NYSE:ABT) Purchased by Lesa Sroufe & CoLesa Sroufe & Co bought a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,689 shares of the healthcare product maker's stocJune 17 at 6:35 AM | marketbeat.comNBT Bank N A NY Sells 4,007 Shares of Abbott Laboratories (NYSE:ABT)NBT Bank N A NY decreased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 3.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 110,401 shares of the healthcare product maker's stock afterJune 17 at 6:24 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Purchased by Chicago Capital LLCChicago Capital LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 15.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 51,416 shares of the healthcare product maker's stock afJune 17 at 5:56 AM | marketbeat.comSchaper Benz & Wise Investment Counsel Inc. WI Sells 4,656 Shares of Abbott Laboratories (NYSE:ABT)Schaper Benz & Wise Investment Counsel Inc. WI lowered its position in Abbott Laboratories (NYSE:ABT - Free Report) by 2.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 161,648 shares of the healthcare product maker's stock after selling 4,656 shares duriJune 17 at 5:46 AM | marketbeat.comVivid Wealth Management LLC Acquires Shares of 19,518 Abbott Laboratories (NYSE:ABT)Vivid Wealth Management LLC acquired a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The firm acquired 19,518 shares of the healthcare product maker's stock, valued at approximately $2,589,000. Abbott LJune 17 at 5:46 AM | marketbeat.comSowell Financial Services LLC Sells 8,301 Shares of Abbott Laboratories (NYSE:ABT)Sowell Financial Services LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 25.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,782 shares of the healthcare productJune 17 at 4:33 AM | marketbeat.comLeerink starts bullish on Boston Scientific and Medtronic, Neutral on AbbottJune 16, 2025 | investing.comAbbott Laboratories (NYSE:ABT) Coverage Initiated by Analysts at Leerink PartnersLeerink Partners assumed coverage on shares of Abbott Laboratories in a research note on Monday. They issued a "market perform" rating and a $143.00 price objective for the company.June 16, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Purchased by QRG Capital Management Inc.QRG Capital Management Inc. grew its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 7.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 346,481 shares of the heJune 16, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by Sagespring Wealth Partners LLCSagespring Wealth Partners LLC increased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 11.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,499 shares of the healthcare productJune 16, 2025 | marketbeat.comMurphy Pohlad Asset Management LLC Invests $428,000 in Abbott Laboratories (NYSE:ABT)Murphy Pohlad Asset Management LLC purchased a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 3,229 shares of the healthcare product maker's stock, valued at approximately $428,000.June 16, 2025 | marketbeat.comJanney Montgomery Scott LLC Sells 18,940 Shares of Abbott Laboratories (NYSE:ABT)Janney Montgomery Scott LLC lessened its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 3.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 596,088 shares of the healthcare product maker's stock after selling 18,94June 16, 2025 | marketbeat.comM. Kraus & Co Sells 2,432 Shares of Abbott Laboratories (NYSE:ABT)M. Kraus & Co lowered its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 3.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,394 shares of the healthcare product maJune 16, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Purchased by Mission Wealth Management LPMission Wealth Management LP grew its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 38.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 34,944 shares of the healthcare product makeJune 16, 2025 | marketbeat.comTrust Point Inc. Has $2.94 Million Position in Abbott Laboratories (NYSE:ABT)Trust Point Inc. lowered its position in Abbott Laboratories (NYSE:ABT - Free Report) by 8.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,173 shares of the healthcare product maker's stock after selling 1,995 shares during the period. TrustJune 16, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) is Cyndeo Wealth Partners LLC's 8th Largest PositionCyndeo Wealth Partners LLC decreased its position in Abbott Laboratories (NYSE:ABT - Free Report) by 1.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 176,726 shares of the healthcare product maker's stock after selling 2,213 shares duringJune 16, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by Hanson & Doremus Investment ManagementHanson & Doremus Investment Management raised its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 97.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 25,398 shares of the healthcare product maker's stockJune 16, 2025 | marketbeat.comBank Pictet & Cie Europe AG Sells 44,492 Shares of Abbott Laboratories (NYSE:ABT)Bank Pictet & Cie Europe AG lessened its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 29.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 108,227 shares of the healthcare product maker's stockJune 16, 2025 | marketbeat.comBrokerages Set Abbott Laboratories (NYSE:ABT) Price Target at $142.59June 16, 2025 | americanbankingnews.comJim Cramer Calls Abbott “Really Excellent”June 15, 2025 | insidermonkey.com Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address ABT Media Mentions By Week ABT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABT News Sentiment▼1.290.69▲Average Medical News Sentiment ABT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABT Articles This Week▼8136▲ABT Articles Average Week Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ISRG News BSX News SYK News MDT News BDX News EW News IDXX News RMD News DXCM News STE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABT) was last updated on 6/20/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredWar-Proof Power Why This "Weird" Government Land Auction Was No Ordinary Sale When 218,000 acres of land... smack in the m...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
